HC Wainwright reiterated their buy rating on shares of Quantum-Si (NASDAQ:QSI - Free Report) in a report issued on Wednesday,Benzinga reports. The firm currently has a $4.00 price objective on the stock.
Separately, Canaccord Genuity Group dropped their target price on Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a research report on Wednesday.
Get Our Latest Report on Quantum-Si
Quantum-Si Price Performance
Shares of QSI traded up $0.02 during trading hours on Wednesday, reaching $0.79. 902,540 shares of the company traded hands, compared to its average volume of 680,192. The business has a fifty day moving average price of $0.86 and a 200-day moving average price of $1.12. Quantum-Si has a 12-month low of $0.70 and a 12-month high of $2.43.
Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.18) EPS for the quarter, topping analysts' consensus estimates of ($0.21) by $0.03. The company had revenue of $0.79 million during the quarter, compared to analysts' expectations of $1.06 million. Quantum-Si had a negative return on equity of 35.42% and a negative net margin of 3,968.84%. On average, equities research analysts predict that Quantum-Si will post -0.71 EPS for the current year.
Institutional Trading of Quantum-Si
Hedge funds have recently modified their holdings of the stock. Jacobs Levy Equity Management Inc. acquired a new position in shares of Quantum-Si in the first quarter worth about $998,000. Vanguard Group Inc. increased its stake in shares of Quantum-Si by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company's stock valued at $10,442,000 after purchasing an additional 82,463 shares in the last quarter. Virtu Financial LLC acquired a new position in Quantum-Si in the 1st quarter worth about $98,000. Public Employees Retirement System of Ohio purchased a new position in Quantum-Si during the first quarter worth approximately $27,000. Finally, Bleakley Financial Group LLC acquired a new stake in Quantum-Si in the first quarter valued at approximately $28,000. Hedge funds and other institutional investors own 39.90% of the company's stock.
About Quantum-Si
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Articles
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
